DEBRA Research – Treatments for EB
As part of DEBRA Austria‘s mission we aim to achieve a world in which Epidermolysis Bullosa (EB) is curable.
DEBRA Research is a non-profit organization and operates worldwide as the research arm of DEBRA Austria. We focus on translational research and clinical development with the goal of creating therapies and cures for EB.
Who we are and what drives us.
DEBRA Research is driven by one goal: to make EB curable. We identify, fund and advance promising therapies, build critical research infrastructure, and unite global experts from science, industry and patient communities to turn innovation into real treatments.
